Actinium Announces Strong Presence at Society of Nuclear Medicine and Molecular Imaging Annual Meeting
NEW YORK, NY--(Marketwired - June 09, 2016) - Company will host an educational event on Monday, June 13th focused on the upcoming Iomab-B Phase 3 SIERRA trial and alpha particle radioimmunotherapy Dr. Joseph Jurcic, Director of Hematologic Malignancies at …